Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979)
- PMID: 7161034
- DOI: 10.1007/BF02043311
Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979)
Abstract
A descriptive epidemiological survey of Myotonia Congenita (MC) and Myotonic Dystrophy (MD) was carried out on the resident population of the City of Turin, Italy. Cases were collected from the Archives of the Neurological Clinic, University of Turin, and from other neurological departments in the city's hospitals. Every patient (and the "healthy" relatives of MD subjects) underwent clinical and EMG re-examination, in order to confirm the initial diagnosis and to investigate the familial distribution of the diseases. The point prevalence rate was 0.9 (+/- 0.6) X 10(-5) for MC and 2.1 (+/- 0.8) X 10(-5) for MD. During the period 1955-1979 the mean annual incidence was 0.3 (+/- 0.2) X 10(-6) for MC and 0.7 (+/- 0.3) X 10(-6) for MD. The incidence-at-birth rate was 1.4 (+/- 1.2) X 10(-5) for MC and 2.9 (+/- 1.8) X 10(-5) for MD. The modalities of inheritance and sex distribution of MC and MD were also studied. Knowledge of epidemiological features of these myopathies is of vital importance for genetic counselling.
Similar articles
-
Myotonia congenita (Thomsen's disease) excluded from the region of the myotonic dystrophy locus on chromosome 19.Hum Genet. 1989 May;82(2):163-6. doi: 10.1007/BF00284051. Hum Genet. 1989. PMID: 2722193
-
[The clinico-epidemiological characteristics of myotonias in Saratov Province].Zh Nevrol Psikhiatr Im S S Korsakova. 1993;93(5):13-7. Zh Nevrol Psikhiatr Im S S Korsakova. 1993. PMID: 8154208 Russian.
-
[Regional clinico-genetic features of myotonias].Zh Nevropatol Psikhiatr Im S S Korsakova. 1986;86(3):342-6. Zh Nevropatol Psikhiatr Im S S Korsakova. 1986. PMID: 2939672 Russian.
-
[Myotonia syndromes].Rev Prat. 1988 Oct 6;38(22):1546-51. Rev Prat. 1988. PMID: 3060972 Review. French. No abstract available.
-
Ion channel mutations in periodic paralysis and related myotonic diseases.Ann N Y Acad Sci. 1993 Dec 20;707:305-16. doi: 10.1111/j.1749-6632.1993.tb38061.x. Ann N Y Acad Sci. 1993. PMID: 9137561 Review. No abstract available.
Cited by
-
Myotonia congenita in northern Finland: an epidemiological and genetic study.J Med Genet. 1998 Apr;35(4):293-6. doi: 10.1136/jmg.35.4.293. J Med Genet. 1998. PMID: 9598722 Free PMC article.
-
Treatment and management of neuromuscular channelopathies.Curr Treat Options Neurol. 2014 Oct;16(10):313. doi: 10.1007/s11940-014-0313-6. Curr Treat Options Neurol. 2014. PMID: 25118992
-
[Congenital myotonic dystrophy in a rural health area].Aten Primaria. 2004 Jan;33(1):53-4. doi: 10.1016/s0212-6567(04)78882-4. Aten Primaria. 2004. PMID: 14746749 Free PMC article. Spanish. No abstract available.
-
Skeletal Muscle Channelopathies.Neurotherapeutics. 2018 Oct;15(4):954-965. doi: 10.1007/s13311-018-00678-0. Neurotherapeutics. 2018. PMID: 30341599 Free PMC article. Review.
-
Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy.J Neuromuscul Dis. 2024;11(2):411-423. doi: 10.3233/JND-230115. J Neuromuscul Dis. 2024. PMID: 38306059 Free PMC article.